Author details

Full Name

Robert Heard

Affiliation

ORCID

Career Start Year

1989

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
34566866	MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis.	Front Neurol	2021
32612571	Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation.	Front Neurol	2020
32006158	The clinical profile of NMOSD in Australia and New Zealand.	J Neurol	2020
28550069	Incidence and prevalence of NMOSD in Australia and New Zealand.	J Neurol Neurosurg Psychiatry	2017
26224184	A new era in the treatment of multiple sclerosis.	Med J Aust	2015
24986155	Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of Neurologists.	J Clin Neurosci	2014
24993136	Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of Neurologists.	J Clin Neurosci	2014
24993135	Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of Neurologists.	J Clin Neurosci	2014
21833088	Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.	Nature	2011
22190364	Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.	Ann Neurol	2011
20187771	Interleukin 7 receptor alpha chain haplotypes vary in their influence on multiple sclerosis susceptibility and response to interferon Beta.	Journal of Interferon and Cytokine Research	2010
21152067	A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis.	PLoS ONE	2010
21049023	A polymorphism in the HLA-DPB1 gene is associated with susceptibility to multiple sclerosis.	PLoS ONE	2010
20463963	Novel approaches to detect serum biomarkers for clinical response to interferon-beta treatment in multiple sclerosis.	PLoS ONE	2010
20415839	Hyperbaric oxygen therapy for multiple sclerosis.	CNS Neuroscience and Therapeutics	2010
20502484	Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis.	Nat Genet	2010
20190274	The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis.	Human Molecular Genetics	2010
20097866	Functionally significant differences in expression of disease-associated IL-7 receptor alpha haplotypes in CD4 T cells and dendritic cells.	Journal of Immunology	2010
19293837	Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor.	Eur J Hum Genet	2009
18406576	CD127 immunophenotyping suggests altered CD4+ T cell regulation in primary progressive multiple sclerosis.	Journal of Autoimmunity	2008
17971048	SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians.		2008
17928869	Haplotypes of the interleukin 7 receptor alpha gene are correlated with altered expression in whole blood cells in multiple sclerosis.	Genes and Immunity	2008
18366677	Genes implicated in multiple sclerosis pathogenesis from consilience of genotyping and expression profiles in relapse and remission.	BMC Medical Genetics	2008
18715196	BAFF is a biological response marker to IFN-beta treatment in multiple sclerosis.	Journal of Interferon and Cytokine Research	2008
17547850	The spectrum of multiple sclerosis.	Current Allergy and Asthma Reports	2007
17261686	Familial effects on the clinical course of multiple sclerosis.	Neurology	2007
16934875	Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans.	J Neuroimmunol	2006
17262998	An investigation of polymorphisms in the 4q1 3.3-21.1 CXC chemokine gene cluster for association with multiple sclerosis in Australians.	Multiple Sclerosis Journal	2006
16872505	An investigation of polymorphisms in the 17q11.2-12 CC chemokine gene cluster for association with multiple sclerosis in Australians.	BMC Medical Genetics	2006
16448664	Analysis of neutralizing antibodies to therapeutic interferon-beta in multiple sclerosis patients: a comparison of three methods in a large Australasian cohort.	Journal of Immunological Methods	2006
16075257	Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis.	Journal of Molecular Medicine	2005
16080120	A high-density screen for linkage in multiple sclerosis.	Am J Hum Genet	2005
15856071	An investigation of NOS2A promoter polymorphisms in Australian multiple sclerosis patients.	European Journal of Human Genetics	2005
14975605	Association of common T cell activation gene polymorphisms with multiple sclerosis in Australian patients.	Journal of Neuroimmunology	2004
14974004	Hyperbaric oxygen therapy for multiple sclerosis.		2004
14575915	A genome-wide screen for linkage disequilibrium in Australian HLA-DRB1*1501 positive multiple sclerosis patients.	Journal of Neuroimmunology	2003
12771260	FDG-PET in paraneoplastic neuropathy.	Neurology	2003
12825072	Identification of 11 novel and common single nucleotide polymorphisms in the interleukin-7 receptor-alpha gene and their associations with multiple sclerosis.	European Journal of Human Genetics	2003
12486604	A genome screen for linkage in Australian sibling-pairs with multiple sclerosis.	Genes and Immunity	2002
12067146	Treatment of multiple sclerosis with hyperbaric oxygen therapy.	Undersea and Hyperbaric Medicine	2001
10871824	T cell receptor beta chain genotyping in Australian relapsing-remitting multiple sclerosis patients.	Multiple Sclerosis Journal	2000
10694840	Evaluation of the apo-1/Fas promoter mva I polymorphism in multiple sclerosis.	Multiple Sclerosis Journal	2000
10519862	Lack of restriction of T cell receptor beta variable gene usage in cerebrospinal fluid lymphocytes in acute optic neuritis.	Journal of Neurology, Neurosurgery and Psychiatry	1999
10439317	The DRB1 Val86/Val86 genotype associates with multiple sclerosis in Australian patients.	Human Immunology	1999
10527398	HLA-DMB gene and HLA-DRA promoter region polymorphisms in Australian multiple sclerosis patients.	Human Immunology	1999
10844781	Angiotrophic large cell lymphoma mimicking multiple sclerosis associated transverse myelitis.	Journal of Clinical Neuroscience	1999
9438209	The CCR5 deletion mutation fails to protect against multiple sclerosis.	Human Immunology	1997
9104579	HLA-DR, -DQA1 and -DQB1 associations in Australian multiple sclerosis patients.		1997
8732474	HLA-DQA1 and -DQB1 genotyping by PCR-RFLP, heteroduplex and homoduplex analysis.		1996
7797612	TAP2 polymorphisms in Australian multiple sclerosis patients.	Journal of Neuroimmunology	1995